Study of Dalotuzumab (MK-0646) in Adults With Solid Tumors (MK-0646-009)

Status Completed

Clinical Trial Summary

This clinical study evaluates the safety, tolerability, pharmacokinetics, and immunogenicity of dalotuzumab (MK-0646) in participants with relapsed or refractory locally advanced or metastatic solid tumors using once weekly and once every other week dose infusion regimens.

The primary study hypothesis is that administration of dalotuzumab as a once weekly and an every other week infusion will be generally safe and well tolerated

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Neoplasm

Clinical Trial Details

NCT number	NCT00694356
Study type	Interventional
Source	Merck Sharp & Dohme Corp.
Contact
Status	Completed
Phase	Phase 1
Start date	August 4, 2008
Completion date	April 28, 2009

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT01441115` - ECI301 and Radiation for Advanced or Metastatic Cancer	Phase 1
Completed	`NCT00199836` - A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer.	Phase 1
Completed	`NCT01672944` - Evaluating Biobanking Educational Tools	N/A
Not yet recruiting	`NCT02226289` - Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic Treatment	Phase 2
Completed	`NCT02759640` - A Phase I Trial of HS-10241 in Solid Tumors	Phase 1
Completed	`NCT02747342` - A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer	Phase 1
Completed	`NCT02746185` - Cancer Associated Thrombosis, a Pilot Treatment Study Using Rivaroxaban	Phase 3
Completed	`NCT02536586` - A Study of LY3023414 in Japanese Participants With Advanced Cancer	Phase 1
Completed	`NCT02309164` - The Use of Acupuncture for Treatment of Chemotherapy-induced Peripheral Neuropathy (CIPN).	N/A
Completed	`NCT02394821` - Odor Management in Fungating Wounds Comparing Metronidazole and Polihexanide	Phase 3
Completed	`NCT01457196` - Development of a Tumor Molecular Analyses Program and Its Use to Support Treatment Decisions	N/A
Completed	`NCT00143533` - Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors	Phase 1
Recruiting	`NCT05450562` - Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors	Phase 1/Phase 2
Completed	`NCT00001835` - Oxaliplatin in Cancer Patients With Impaired Kidney Function	Phase 1
Completed	`NCT00001341` - A Phase I Trial of ZD1694 (TOMUDEX), an Inhibitor of Thymidylate Synthase, in Pediatric Patients With Advanced Neoplastic Disease	Phase 1
Completed	`NCT01425008` - Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma	Phase 1
Recruiting	`NCT05101798` - The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial	Phase 2
Completed	`NCT01920061` - A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)	Phase 1
Terminated	`NCT03251924` - A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors	Phase 1/Phase 2
Active, not recruiting	`NCT02851706` - Natural History of and Specimen Banking for People With Tumors of the Central Nervous System